Showing results (51-60 of 55) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Oncotarget|August 27, 2016
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patientsGijs G Zom, Marij J P Welters, Nikki M Loof, et al.Proceedings of the National Academy of Sciences of the United States of America|July 26, 2022
Mechanism-based heparanase inhibitors reduce cancer metastasis in vivoCasper de Boer, Zachary Armstrong, Vincent A J Lit, et al.Frontiers in Chemistry|October 23, 2019
Systematic Dual Targeting of Dendritic Cell C-Type Lectin Receptor DC-SIGN and TLR7 Using a Trifunctional Mannosylated AntigenRui-Jun Eveline Li, Tim P Hogervorst, Silvia Achilli, et al.Chembiochem : a European Journal of Chemical Biology|November 12, 2020
Simplified Monopalmitoyl Toll-like Receptor 2 Ligand Mini-UPam for Self-Adjuvanting Neoantigen-Based Synthetic Cancer VaccinesThomas C van den Ende, Jeroen M M Heuts, Geoffroy P P Gential, et al.Journal for Immunotherapy of Cancer|October 19, 2022
Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesionsFrank M Speetjens, Marij J P Welters, Marije Slingerland, et al.Pageof 6